Ci. Obialo et al., HEMODIALYSIS VASCULAR ACCESS - VARIABLE THROMBUS-FREE SURVIVAL IN 3 SUBPOPULATIONS OF BLACK PATIENTS, American journal of kidney diseases, 31(2), 1998, pp. 250-256
Hemodialysis vascular access related problems account for most hospita
lizations in chronic hemodialysis patients. Although some co-morbid ri
sk factors for early fistula failures have been described, a great dea
l of unknown exists as to why access survival is favorable in some pat
ients. In this longitudinal study, fistulae patency and thrombosis epi
sodes were monitored from placement date In three groups of end stage
renal disease (ESRD) patients who have been on dialysis for greater th
an or equal to 90 days. Thirty-six patients (29 male; 80%) with a mean
age of 42 +/- 2 years were monitored. The groups consisted of eight p
atients with biopsy-confirmed focal segmental glomerulosclerosis (FSGS
), 13 with acquired immunodeficiency syndrome related nephropathy (hum
an immunodeficiency virus [HIV]), and 15 with hypertensive ESRD (hyper
tensive nephrosclerosis [HTN]) who served as controls. Diabetics and p
atients aged greater than or equal to 64 years were excluded. Twenty-f
ive of 36 (69%) fistulae were prosthetic (AVG), while 11 (31%) were na
tive (AVF). The FSGS group was more likely to have an AVG (87.5%), whi
le 54% of the HIV group had an AVG. The thrombosis event rate was sign
ificantly greater among the FSGS patients (3/patient-year) than the HI
V (0.15/patient-year) and HTN (O.5/patient-year) patients (P < 0.0001
and P < 0.002, respectively). The mean thrombosis free duration for bo
th AVG and AVF among the HIV and HTN groups were 318.5 +/- 17 days and
311.7 +/- 22.5 days, respectively. These were significantly greater t
han in the FSGS group (26.5 +/- 7 days; P < 0.0001). The cumulative I-
year patency rate for AVG among the HIV and HTN groups was 85% and 65%
, respectively, while that of the FSGS group was 0%. Kaplan-Meier haza
rd analysis showed that all groups were at risk of access thrombosis a
s time progressed, but the FSGS group had the highest risk of access t
hrombosis, which began from the date of placement and increased expone
ntially with time. The increased thrombosis rate among the patients in
the FSGS group correlated with their weight (R = 0.8, P = 0.003) and
pre-ESRD 24-hour urinary protein excretion (R = 0.9, P = 0.001). The H
IV status appeared to confer enhanced hemodialysis access survival. Th
is may be related to the high rate of native fistulae placement and fa
vorable vascular reactivity to shear stress. Accelerated atheroscleros
is and small caliber vessels may be responsible for the poor fistulae
outcome among the FSGS group. More studies will be necessary to furthe
r explore these findings. (C) 1998 by the National Kidney Foundation,
Inc.